Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed Multiple Myeloma

PURPOSE: Despite recent advances, multiple myeloma remains incurable and most patients eventually develop progressive disease. Allogeneic hematopoietic stem cell transplantation (allo HCT) offers a potentially curative option in 10–20% of patients with relapsed or refractory disease. We evaluated th...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Efebera, Yvonne A., Qureshi, Sofia R., Cole, Suzanne M., Saliba, Rima, Pelosini, Matteo, Patel, Ronak M., Koca, Ebru, Mendoza, Floralyn L, Wang, Michael, Shah, Jatin, Alousi, Amin, Hosing, Chitra, Popat, Uday, Kebriaei, Partow, Anderlini, Paolo, Khouri, Issa F., Champlin, Richard, Giralt, Sergio, Qazilbash, Muzaffar H.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2010
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3414196/
https://ncbi.nlm.nih.gov/pubmed/20178853
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2010.02.015
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky